Dynamics-Driven Characterization of Flavonol Binding to the HPV16 E6 Oncoprotein: Energetic and Molecular Interaction Analysis
Abstract
Human papillomavirus type 16 (HPV16) E6 is a key viral oncoprotein that suppresses apoptotic signaling and promotes malignant progression, making it an important therapeutic target. Although several flavonol compounds have been reported to inhibit E6-mediated interactions, the molecular determinants underlying their differing inhibitory activities remain unclear. In this study, we investigated six experimentally validated flavonol inhibitors using molecular docking, explicit-solvent molecular dynamics simulations, MM/PBSA and MM/GBSA binding free-energy calculations, per-residue energy decomposition, and hydrogen-bond occupancy analysis. Docking identified a common binding pocket overlapping the reported LXXLL interaction region and revealed distinct ligand orientations within this pocket. The 300 ns simulations showed bounded RMSD behavior and maintained overall structural compactness while revealing ligand-dependent conformational fluctuations. Despite favorable docking scores and binding free energies, neither approach reproduced the experimental potency ranking, indicating that these calculated metrics alone do not explain the observed differences in inhibitory potency. Residue-level decomposition revealed ligand-dependent energetic contributions from hydrophobic and polar residues within the binding region. Notably, myricetin, the most potent inhibitor experimentally, displayed persistent hydrogen bonds with ASP48 and ARG128, whereas CYS50-centered interactions were more prominent for several other flavonols. These findings indicate that no single interaction accounts for the experimental potency pattern and instead support a ligand-dependent recognition mechanism involving orientation, residue-level energetic contributions, and persistent intermolecular contacts, providing molecular insight for future HPV16 E6 inhibitor optimization.